HGHRX
Price
$37.40
Change
-$0.59 (-1.55%)
Updated
Jun 2 closing price
Net Assets
722.86M
VGHAX
Price
$78.94
Change
-$1.24 (-1.55%)
Updated
Jun 2 closing price
Net Assets
36.84B
Interact to see
Advertisement

HGHRX vs VGHAX

Header iconHGHRX vs VGHAX Comparison
Open Charts HGHRX vs VGHAXBanner chart's image
HGHRX vs VGHAX Comparison Chart in %
View a ticker or compare two or three
VS
HGHRX vs. VGHAX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HGHRX is a StrongBuy and VGHAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VGHAX has more cash in the bank: 36.8B vs. HGHRX (723M). VGHAX pays higher dividends than HGHRX: VGHAX (1.16) vs HGHRX (0.00). HGHRX was incepted earlier than VGHAX: HGHRX (19 years) vs VGHAX (25 years). HGHRX (1.66) is less costly to investors than VGHAX (0.32). HGHRX (49.00) and VGHAX (47.00) have comparable annual turnover. HGHRX has a lower initial minimum investment than VGHAX: HGHRX (0) vs VGHAX (50000). HGHRX annual gain was more profitable for investors over the last year : 14.39 vs. VGHAX (10.03). HGHRX return over 5 years is better than : -11.75 vs. VGHAX (-13.95).
HGHRXVGHAXHGHRX / VGHAX
Total Expense Ratio1.660.32519%
Annual Report Gross Expense Ratio1.660.32519%
Fund Existence19 years25 years-
Gain YTD-3.628-7.03852%
Front LoadN/AN/A-
Min. Initial Investment050000-
Min. Initial Investment IRAN/AN/A-
Net Assets723M36.8B2%
Annual Yield % from dividends0.001.16-
Returns for 1 year14.3910.03143%
Returns for 3 years5.15-9.83-52%
Returns for 5 years-11.75-13.9584%
Returns for 10 years11.47-8.27-139%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MIRTX34.50N/A
N/A
MFS Massachusetts Investors Tr R2
VCGAX37.34N/A
N/A
VALIC Company I Systematic Core Fund
VNVAX20.71N/A
N/A
Natixis Vaughan Nelson Mid Cap A
MSJAX20.42N/A
N/A
Morgan Stanley Global Endurance A
WOFRX67.12N/A
N/A
Allspring Opportunity R6